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We report a 6-year-old female child who was diagnosed as abdominal tuberculosis and started on first-line four drug antitubercular therapies (ATT). She developed 
symptomatic pancytopenia 2 months after the start of ATT in 
the form of congestive cardiac failure due to severe anemia in 
addition to concurrent hepatitis. She required multiple packed 
red blood cells (RBC) transfusions and was transiently shifted to 
second-line ATT. She recovered completely and was restarted on 
first-line ATT under strict hematological and liver function test 
monitoring. She has been under follow-up for the past 3 months 
and has remained asymptomatic thereafter. The case report has 
been framed using the CARE Guidelines [1].
CASE REPORT
A 6-year-old female child presented to the emergency department 
with difficulty in breathing for 1 day associated with increased rate 
of breathing and chest indrawing. There was no history of cough, 
fever, abdominal pain, bluish discoloration, altered sensorium, or 
loss of consciousness. Examination revealed tachycardia (heart 
rate 132/min), tachypnea (respiratory rate 30/min), severe pallor, 
and knuckle hyperpigmentation. Grade II systolic murmur was 
heard on auscultation. The liver was palpable 4 cm below the right 
subcostal margin while spleen was not palpable. Investigations 
showed hemoglobin (Hb) 1.9 mg/dL, total leukocyte count 
(TLC) 2500/mm3, and platelet count 39,000/mm3. She had 
hyperbilirubinemia (bilirubin total/conjugated 2.1/1 mg/dL), 
elevated aminotransferases (aspartate transaminase [AST]/
alanine transaminase [ALT] 650/398 IU/L), and raised lactate 
dehydrogenase (1150 U/L). Coagulation profile was deranged 
with prothrombin time (PT) 22 s (control: 15 s), activated 
partial thromboplastin time 44 s (control: 30 s), PT index 64%, 
and International Normalized Ratio (INR) 1.8. The patient was 
managed with non-invasive ventilation and packed red blood cell 
transfusions. First-line ATT was stopped and second-line ATT 
started.
2 months before admission, she was hospitalized with the 
complaints of intermittent fever for 1 month and abdominal 
distension for 1 week before admission. On abdominal computed 
tomography (CT), there were necrotic and conglomerated 
abdominal, pelvic and epiphrenic lymphadenopathy, 
hepatosplenomegaly, and diffuse mental thickening suggestive 
of abdominal tuberculosis (Fig. 1). She was started on daily 
ATT (isoniazid at 10 mg/kg/day, rifampicin at 15 mg/kg/day, 
ethambutol at 20 mg/kg/day, and pyrazinamide at 30 mg/kg/
day) for the same. As per the parents, adherence to the treatment 
regime was good.
On further investigations during the current hospitalization, 
hepatitis B surface antigen, anti-hepatitis C antibody, serologies 
for hepatitis A, hepatitis E, human immunodeficiency 
virus, and autoantibodies (antinuclear, anti-smooth muscle, 
antimitochondrial, anti-liver kidney muscle, and anti-parietal 
cell) were negative. Peripheral blood smear, indirect bilirubin, 
and G6PD levels were within normal limits. Urine for Hb, direct 
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Coombs test, and sputum-for-hemosiderin laden-macrophage 
was negative. Given the temporal correlation, absence of other 
etiologies and a score of 6 on Naranjo Probability, a possibility 
of drug-induced pancytopenia, and hepatitis were considered [2]. 
The concurrent antitubercular medications were withheld 
and the child was started on modified regimen consisting of 
ofloxacin, ethambutol, and streptomycin. The liver function tests 
subsequently improved with total serum bilirubin 0.7 mg/dL, 
AST/ALT, 46/72 IU/L, and hematological parameters recovered 
with Hb 8.1 mg/dL, TLC 7700/mm3, and platelet count 175,000/
mm3. A repeat abdominal CT scan showed multiple large 
conglomerated mesenteric and retroperitoneal lymphadenopathy 
and hepatosplenomegaly (Fig. 2). Radiologically, there was 
neither deterioration nor improvement. First-line ATT was 
reintroduced starting with Isoniazid at 50 mg/day which was 
gradually increased to 150 mg/day over 3 days followed by 
Rifampicin at 75 mg/day increased to 250 mg/day over 3 days. 
Complete blood counts and liver function tests (LFTs) were 
regularly monitored during this period. The child was discharged 
in stable condition after 4 weeks of hospitalization. The child was 
asymptomatic when he came for follow-up after 3 months, and 
his hematological parameters and LFTs were normal.
DISCUSSION
Tuberculosis is a significant public health concern affecting 
people of all age groups in developing countries. From the earlier 
thrice a week regimen, a daily drug regimen using fixed-dose 
combinations is now the preferred strategy [3]. For abdominal 
tuberculosis, an intensive phase of 2 months with isoniazid, 
rifampicin, pyrazinamide, and ethambutol followed by a 
continuation phase of 4 months with isoniazid and rifampicin is 
recommended.
Drug-induced hematological disorders can affect red cells, 
white cells, platelets, and the coagulation system, causing hemolytic 
anemia, red cell aplasia, sideroblastic anemia, megaloblastic 
anemia, polycythemia, aplastic anemia, and leukocytosis. It has 
been seen that agranulocytosis can occur in tuberculosis patients 
taking isoniazid and rifampicin [4]. However, all the patients in 
this case series were adults, and similar reactions in children have 
not been reported. Leukopenia and thrombocytopenia with ATT 
have also been observed [5,6]. Pancytopenia following ATT in 
adults has been attributed to idiosyncratic reaction to streptomycin 
and hemophagocytosis in two separate reports [7,8]. Idiosyncratic 
reaction, malabsorbtion, and interference with iron metabolism or 
hemolysis can also cause hematological abnormalities in patients 
on ATT [9]. However, clinically significant pancytopenia leading 
to congestive cardiac failure requiring multiple packed RBC 
transfusions occurring in pediatric age group due to ATT has not 
been reported previously.
Pancytopenia can be a manifestation of disseminated 
tuberculosis in children. Disseminated tuberculosis complicated 
by macrophage activation syndrome can also present as 
pancytopenia. Hemophagocytic lymphohistiocytosis (HLH) has 
also been diagnosed in patients with tuberculosis who present 
with cytopenias, organomegaly, and coagulopathy [10] In our 
case, there were no clinical or radiological signs of dissemination, 
the 2004 diagnostic criteria for HLH was not fulfilled, and there 
was an improvement in symptoms after ATT was withheld. 
Drug-induced lupus erythematosus due to isoniazid presenting as 
pancytopenia has been reported, with positive antinuclear, anti-ds 
DNA and anti-histone antibodies [11]. However, ANA and anti-ds 
DNA were negative in our patient.
Drug-induced liver injury (DILI) is defined as an increase 
in ALT ≥5 times the upper limit of normal (ULN) or ALP 
≥2 times ULN or ALT ≥3 times ULN with bilirubin ≥2 times 
ULN following drug exposure [12]. Pediatric acute liver failure 
(ALF) is defined as evidence of liver dysfunction within 8 weeks 
of onset of symptoms, correctable coagulopathy with INR >1.5 
in patients with hepatic encephalopathy, or INR >2.0 in patients 
without encephalopathy and no evidence of chronic liver disease 
either at presentation or in the past. Antibiotics and ATT are a 
common cause of DILI-LF. In our case, the laboratory values 
were consistent with DILI not progressing into ALF. Animal 
studies for investigation of the mechanism of rifampicin-induced 
liver injury have identified the involvement of PPARγ signaling 
pathway and cytochrome P450 [13]. A population study done 
on isoniazid-induced liver injury in Singapore showed that 
association between single nucleotide polymorphisms in NAT2 
slow acetylates and isoniazid-DILI was significant and could be 
used for the prediction of DILI [14].
Transaminitis with concurrent pancytopenia commonly 
occurs due to viral hepatitis, but a drug-induced event must also 
be kept as a differential diagnosis. It has been reported previously 
Figure 1: Contrast enhanced CT (CECT) of abdomen 
showing multiple enlarged necrotic lymph nodes in mesentery, 
retroperitoneum and encasing common iliac vessels. Hepatomegaly 
and right pleural effusion also seen
Figure 2: Contrast enhanced CT abdomen showing multiple 
conglomerated lymph nodes with central necrosis in mesentery, 
retroperitoneum, peri-pancreatic region and along the iliac vessels
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with drugs like terbinafine [15]. The mechanism is uncertain 
but likely due to an idiosyncratic reaction or immunologically 
mediated hypersensitivity, involving immunoglobulin E, G, M, or 
antigen-antibody complexes. In our case, the pancytopenia with 
concurrent hepatitis points to an allergic reaction to first-line ATT 
or an idiosyncratic reaction. It is therefore advised that a complete 
hemogram along with LFTs must be done at regular intervals 
in children taking ATT. This could detect any drug-related side 
effect promptly and prevent the development of pancytopenia-
induced complications such as congestive cardiac failure as seen 
in our patient.
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